Background: Arterial wall imaging has been increasingly employed in clinical trials to evaluate the impact of medical therapies on progression of atherosclerosis.
Scope: A selective overview of major findings from clinical trials that assessed the impact of medical therapies on atherosclerosis progression.
Findings: Targeting established risk factors including LDL cholesterol, HDL cholesterol and blood pressure has a beneficial impact on disease progression.
Conclusion: As a result, vascular imaging has been employed in the early evaluation of experimental therapies.